Selected research
Industry Research
Drug Ingredient Testing Service Industry Research Report 2026
Market perspective
The global Drug Ingredient Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Ingredient Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Ingredient Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Ingredient Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Ingredient Testing Service include Eurofins Scientific, Nelson Labs, Creative Proteomics, SGS S.A., CPT Labs, ADPEN Laboratories, Cotecn, Curia Global and Evans Analytical Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Ingredient Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Ingredient Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Ingredient Testing Service Market by Company
Eurofins Scientific
Nelson Labs
Creative Proteomics
SGS S.A.
CPT Labs
ADPEN Laboratories
Cotecn
Curia Global
Evans Analytical Group
Vetter Pharma
Almac
Q Laboratories
Contract Laboratory
Consumer Product Testing Company
Tentamus Group
Auriga Research
Drug Ingredient Testing Service Segment by Type
Veterinary Drug Testing
Drug Testing
Pesticide Testing
Drug Ingredient Testing Service Segment by Application
Drug Research and Development
Quality Control
Clinical Research
Drug Supervision
Others
Drug Ingredient Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Ingredient Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Ingredient Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Ingredient Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Ingredient Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Veterinary Drug Testing
- Drug Testing
- Pesticide Testing
Applications
- Drug Research and Development
- Quality Control
- Clinical Research
- Drug Supervision
- Others
Companies covered
- Eurofins Scientific
- Nelson Labs
- Creative Proteomics
- SGS S.A.
- CPT Labs
- ADPEN Laboratories
- Cotecn
- Curia Global
- Evans Analytical Group
- Vetter Pharma
- Almac
- Q Laboratories
- Contract Laboratory
- Consumer Product Testing Company
- Tentamus Group
- Auriga Research
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Ingredient Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Veterinary Drug Testing
- 2.2.3 Drug Testing
- 2.2.4 Pesticide Testing
- 2.3 Drug Ingredient Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Research and Development
- 2.3.3 Quality Control
- 2.3.4 Clinical Research
- 2.3.5 Drug Supervision
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Drug Ingredient Testing Service Breakdown Data by Type
- 3.1 Global Drug Ingredient Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Ingredient Testing Service Forecasted Market Size by Type (2027-2032)
4 Drug Ingredient Testing Service Breakdown Data by Application
- 4.1 Global Drug Ingredient Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Ingredient Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Ingredient Testing Service Market Perspective (2021-2032)
- 5.2 Global Drug Ingredient Testing Service Growth Trends by Region
- 5.2.1 Global Drug Ingredient Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Ingredient Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Ingredient Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Ingredient Testing Service Market Dynamics
- 5.3.1 Drug Ingredient Testing Service Industry Trends
- 5.3.2 Drug Ingredient Testing Service Market Drivers
- 5.3.3 Drug Ingredient Testing Service Market Challenges
- 5.3.4 Drug Ingredient Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Ingredient Testing Service Players by Revenue
- 6.1.1 Global Top Drug Ingredient Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Drug Ingredient Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Ingredient Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Ingredient Testing Service Head Office and Area Served
- 6.4 Global Drug Ingredient Testing Service Players, Product Type & Application
- 6.5 Global Drug Ingredient Testing Service Manufacturers Established Date
- 6.6 Global Drug Ingredient Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Ingredient Testing Service Market Size (2021-2032)
- 7.2 North America Drug Ingredient Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Ingredient Testing Service Market Size by Country (2021-2026)
- 7.4 North America Drug Ingredient Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Ingredient Testing Service Market Size (2021-2032)
- 8.2 Europe Drug Ingredient Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Ingredient Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Drug Ingredient Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Ingredient Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Ingredient Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Ingredient Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Ingredient Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Ingredient Testing Service Market Size (2021-2032)
- 10.2 South America Drug Ingredient Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Ingredient Testing Service Market Size by Country (2021-2026)
- 10.4 South America Drug Ingredient Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Ingredient Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Ingredient Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Ingredient Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Ingredient Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.1.4 Eurofins Scientific Drug Ingredient Testing Service Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Nelson Labs
- 12.2.1 Nelson Labs Company Information
- 12.2.2 Nelson Labs Business Overview
- 12.2.3 Nelson Labs Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.2.4 Nelson Labs Drug Ingredient Testing Service Product Portfolio
- 12.2.5 Nelson Labs Recent Developments
- 12.3 Creative Proteomics
- 12.3.1 Creative Proteomics Company Information
- 12.3.2 Creative Proteomics Business Overview
- 12.3.3 Creative Proteomics Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.3.4 Creative Proteomics Drug Ingredient Testing Service Product Portfolio
- 12.3.5 Creative Proteomics Recent Developments
- 12.4 SGS S.A.
- 12.4.1 SGS S.A. Company Information
- 12.4.2 SGS S.A. Business Overview
- 12.4.3 SGS S.A. Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.4.4 SGS S.A. Drug Ingredient Testing Service Product Portfolio
- 12.4.5 SGS S.A. Recent Developments
- 12.5 CPT Labs
- 12.5.1 CPT Labs Company Information
- 12.5.2 CPT Labs Business Overview
- 12.5.3 CPT Labs Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.5.4 CPT Labs Drug Ingredient Testing Service Product Portfolio
- 12.5.5 CPT Labs Recent Developments
- 12.6 ADPEN Laboratories
- 12.6.1 ADPEN Laboratories Company Information
- 12.6.2 ADPEN Laboratories Business Overview
- 12.6.3 ADPEN Laboratories Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.6.4 ADPEN Laboratories Drug Ingredient Testing Service Product Portfolio
- 12.6.5 ADPEN Laboratories Recent Developments
- 12.7 Cotecn
- 12.7.1 Cotecn Company Information
- 12.7.2 Cotecn Business Overview
- 12.7.3 Cotecn Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.7.4 Cotecn Drug Ingredient Testing Service Product Portfolio
- 12.7.5 Cotecn Recent Developments
- 12.8 Curia Global
- 12.8.1 Curia Global Company Information
- 12.8.2 Curia Global Business Overview
- 12.8.3 Curia Global Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.8.4 Curia Global Drug Ingredient Testing Service Product Portfolio
- 12.8.5 Curia Global Recent Developments
- 12.9 Evans Analytical Group
- 12.9.1 Evans Analytical Group Company Information
- 12.9.2 Evans Analytical Group Business Overview
- 12.9.3 Evans Analytical Group Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.9.4 Evans Analytical Group Drug Ingredient Testing Service Product Portfolio
- 12.9.5 Evans Analytical Group Recent Developments
- 12.10 Vetter Pharma
- 12.10.1 Vetter Pharma Company Information
- 12.10.2 Vetter Pharma Business Overview
- 12.10.3 Vetter Pharma Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.10.4 Vetter Pharma Drug Ingredient Testing Service Product Portfolio
- 12.10.5 Vetter Pharma Recent Developments
- 12.11 Almac
- 12.11.1 Almac Company Information
- 12.11.2 Almac Business Overview
- 12.11.3 Almac Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.11.4 Almac Drug Ingredient Testing Service Product Portfolio
- 12.11.5 Almac Recent Developments
- 12.12 Q Laboratories
- 12.12.1 Q Laboratories Company Information
- 12.12.2 Q Laboratories Business Overview
- 12.12.3 Q Laboratories Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.12.4 Q Laboratories Drug Ingredient Testing Service Product Portfolio
- 12.12.5 Q Laboratories Recent Developments
- 12.13 Contract Laboratory
- 12.13.1 Contract Laboratory Company Information
- 12.13.2 Contract Laboratory Business Overview
- 12.13.3 Contract Laboratory Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.13.4 Contract Laboratory Drug Ingredient Testing Service Product Portfolio
- 12.13.5 Contract Laboratory Recent Developments
- 12.14 Consumer Product Testing Company
- 12.14.1 Consumer Product Testing Company Company Information
- 12.14.2 Consumer Product Testing Company Business Overview
- 12.14.3 Consumer Product Testing Company Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.14.4 Consumer Product Testing Company Drug Ingredient Testing Service Product Portfolio
- 12.14.5 Consumer Product Testing Company Recent Developments
- 12.15 Tentamus Group
- 12.15.1 Tentamus Group Company Information
- 12.15.2 Tentamus Group Business Overview
- 12.15.3 Tentamus Group Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.15.4 Tentamus Group Drug Ingredient Testing Service Product Portfolio
- 12.15.5 Tentamus Group Recent Developments
- 12.16 Auriga Research
- 12.16.1 Auriga Research Company Information
- 12.16.2 Auriga Research Business Overview
- 12.16.3 Auriga Research Revenue in Drug Ingredient Testing Service Business (2021-2026)
- 12.16.4 Auriga Research Drug Ingredient Testing Service Product Portfolio
- 12.16.5 Auriga Research Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst